Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: Analysis of 7510 patients in China as part of CREATE-ECLA study

National Medical Journal of China

Volumn 88, Issue 26, 2008, Pages 1806-1810

  Yang, Yan Min ^a   Zhu, Jun ^a   Tan, Hui Qiong ^a   Liang, Yan ^a   Zhang, Yan ^a   Li, Ying ^a   Li, Jian Dong ^a   Liu, Li Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Glucose insulin potassium; Myocardial infarction

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM; ANTIDIABETIC AGENT; CARDIOPLEGIC AGENT; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOGENIC SHOCK; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FOLLOW UP; HEART ARREST; HEART FAILURE; HEART REINFARCTION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PHLEBITIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

AGED; CARDIOPLEGIC SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POTASSIUM; TREATMENT OUTCOME;

EID: 77954767473     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sodi-Pallares D, Testelli MR, Fishleder BL, Effects of an intravenous infusion of potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol, 1962, 9: 166-181.
2. Yusuf, S, Mehta SR, Diaz, R, et al. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction. Heart J, 2004, 148: 1068-1078. (Pubitemid 39646985)
3. Oliver MF, Opie LH. Effects of glucose, and fatty acids on myocardial ischemia and arrhythmias. Lancet, 1994, 343: 155-158.
4. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation, 2000, 101: 2090-2094. (Pubitemid 30233174)
5. Obeid AI, Varrier RL, Lown B. Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart. Circ Res, 1978, 43: 601-608. (Pubitemid 9022305)
6. Philippe GS, Robert JG, Joel MG, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardial, 2002, 90: 358-363.
7. Metha SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA, 2005, 293: 437-446.
8. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet, 2000, 355: 773-778. (Pubitemid 30128815)
9. Wahab NN, Cowden EA, Pearce NJ, et al. ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol, 2002, 40: 1748-1754.
10. Diaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA, 2007, 298: 2399-2405. (Pubitemid 350190781)
11. Chaudhuri A, Janicke D, Wilson M, et al. Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction. Am J Cardiol, 2007, 100: 1614-1618. (Pubitemid 350122327)